Recent News

By Category: Biotechnology

PharmAthene Awarded 50% Profit Split on Worldwide Sales of Smallpox Antiviral

(PR Newswire) PharmAthene filed the lawsuit against SIGA in December 2006 citing PharmAthene's interest in ST-246, an orally available smallpox antiviral drug candidate. "We are extremely pleased with the Court's decision," remarked Eric I. Richman, President and …

Brazil Approves Biotech Dry Beans

(Truth about Trade & Technology) Brazil is the world's second largest producer of biotech crops and the Brazilian National Technical Commission on Biosafety has just approved a biotech dry bean for human consumption that is resistant to golden mosaic virus. …

PharmAthene Wins Rights to Profit From Siga Smallpox Drug

(BusinessWeek) Siga Technologies Inc. must share with PharmAthene Inc. profit from sales of a smallpox drug that may total more than $400 million, a judge ruled. Siga plunged as much as 38 percent in Nasdaq trading. Delaware Chancery Court Judge …

Jordan’s Prince Hassan calls for developing monitoring systems to protect … – Zawya (subscription)

Jordan's Prince Hassan calls for developing monitoring systems to protect …Zawya (subscription)In an address at the opening session of the 3rd Biosafety and Biosecurity International Conference, he stressed the need to subject the storage of hazardous materials and the regular inspection of installations to rigorous international standards. …and more »

Emergent BioSolutions Co-Hosts Biopreparedness Conference with the French High…

(MarketWatch) Emergent BioSolutions Inc. is co-hosting “Anthrax: Threat and Response,” a conference organized by the French High Committee for Civil Defense to discuss anthrax preparedness and response. The conference, which brings together military and civilian representatives involved in biological threat management in France, features topics on research programs, threat detection, hospital and medical chain preparedness,  Read More »